Hineloran je leki koji deluje kao selektivni dopaminski agonist za D2 podtipe.[1][2][3]

Hineloran
IUPAC ime
(5aR,9aR)-6-propil-5a,7,8,9,9a,10-heksahidro-5H-pirido[2,3-g]hinazolin-2-amin
Identifikatori
CAS broj97548-97-5 ДаY
ATC kodnone
PubChemCID 57242
UNIIZ0X4VT3Y1Q ДаY
KEGGD05677 ДаY
ChEMBLCHEMBL155731 ДаY
Hemijski podaci
FormulaC14H22N4
Molarna masa246,350 g/mol
  • CCCN1CCC[C@H]2[C@H]1CC3=CN=C(N=C3C2)N

Reference

уреди
  1. ^ Caine SB, Negus SS, Mello NK, Patel S, Bristow L, Kulagowski J, Vallone D, Saiardi A, Borrelli E (2002). „Role of dopamine D2-like receptors in cocaine self-administration: studies with D2 receptor mutant mice and novel D2 receptor antagonists”. Journal of Neuroscience. 22 (7): 2977—88. PMID 11923462. 
  2. ^ Gasior M, Paronis CA, Bergman J (2004). „Modification by dopaminergic drugs of choice behavior under concurrent schedules of intravenous saline and food delivery in monkeys”. The Journal of Pharmacology and Experimental Therapeutics. 308 (1): 249—59. PMID 14563783. doi:10.1124/jpet.103.052795. 
  3. ^ Brooks JM, Sarter M, Bruno JP (2007). „D2-like receptors in nucleus accumbens negatively modulate acetylcholine release in prefrontal cortex”. Neuropharmacology. 53 (3): 455—63. PMC 2000917 . PMID 17681559. doi:10.1016/j.neuropharm.2007.06.006. 

Vidi još

уреди

Spoljašnje veze

уреди


 Molimo Vas, obratite pažnju na važno upozorenje
u vezi sa temama iz oblasti medicine (zdravlja).